Skip to content

Insider · CIK 0001919434

Pamela W. Montgomery

officer

Files at NUTX (Nutex Health Inc.). First filing Mar 16, 2026, latest Mar 16, 2026.

In brief

Pamela W. Montgomery files SEC Form 4 as officer at NUTX (Nutex Health Inc.). Since Mar 16, 2026, Pamela W. Montgomery has reported 1 open-market buy worth $7,021 and 0 open-market sells worth $0, the latest filed on Mar 16, 2026.

A track record needs three past buys with six months of prices behind them; Pamela W. Montgomery has 0, so none is measured yet.

The newest scored trade: bought $7,021 of NUTX on Mar 13, 2026, filed Mar 16, 2026, scored 38 (weak). In the last 12 months: 1 buy worth $7,021 and 0 sells worth $0.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$7,021 bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

NUTX: Nutex Health Inc.

NUTXOct 9, 2026 · close 206.29

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
38Weak
NUTXbuy 4
Nutex Health Inc.
$7,021
79 shares
+3%+94% from low-53% from high

Transactions

Every row this insider has filed, 10 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 13, 2026NUTX
Nutex Health Inc.
POpen-market purchase
Common Stock
+79$88.87$7,0212,758Mar 16, 2026
Mar 10, 2026NUTX
Nutex Health Inc.
MOption exercise
Restricted Stock Unitderivative
+1,523$0.00$04,441Mar 16, 2026
Mar 10, 2026NUTX
Nutex Health Inc.
MOption exercise
Common Stock
+2,084$0.00$03,455Mar 11, 2026
Mar 10, 2026NUTX
Nutex Health Inc.
FTax withholding
Common Stock
-776$86.22$67k2,679Mar 11, 2026
Mar 10, 2026NUTX
Nutex Health Inc.
MOption exercise
Restricted Stock Unitsderivative
+1,525$0.00$05,217Mar 11, 2026
Mar 1, 2025NUTX
Nutex Health Inc.
MOption exercise
Common Stock
+111$0.00$0411Apr 14, 2025
Apr 4, 2025NUTX
Nutex Health Inc.
FTax withholding
Common Stock
-24$72.10$1,730387Apr 14, 2025
Mar 1, 2025NUTX
Nutex Health Inc.
MOption exercise
Common Stock
+1,250$0.00$01,637Apr 14, 2025
Apr 4, 2025NUTX
Nutex Health Inc.
FTax withholding
Common Stock
-266$72.10$19k1,371Apr 14, 2025
Mar 10, 2025NUTX
Nutex Health Inc.
MOption exercise
Restricted Stock Unitsderivative
+2,500$0.00$05,000Apr 14, 2025

Questions about Pamela W. Montgomery

Answered from the filings on this page, as of the latest one.

Is Pamela W. Montgomery buying or selling?

In the last 12 months Pamela W. Montgomery reported 1 open-market buy worth $7,021 and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $7,021 of NUTX on Mar 13, 2026. Grants, option exercises and tax withholding are not counted.

How did Pamela W. Montgomery's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Pamela W. Montgomery has 0.

Where does Pamela W. Montgomery file Form 4?

Pamela W. Montgomery has filed Form 4 at NUTX (Nutex Health Inc.) as Chief Legal Officer-Healthcare. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Pamela W. Montgomery: insider trades and track record | InsiderTell